News
LLY
775.76
+1.04%
8.00
Resmed Stock Sees Alarming Drop Alongside a New Obstructive Sleep Apnea Treatment Rival
TipRanks · 34m ago
Better Buy: Eli Lilly or Novo Nordisk?
The Motley Fool · 41m ago
These Stocks Are Moving the Most Today: Honda, Nissan, Qualcomm, Eli Lilly, Tesla, Nordstrom, and More
Barron‘s · 1h ago
Eli Lilly Stock Jumps on FDA Approval of Obstructuve Sleep Apnea Treatment
TipRanks · 1h ago
Lilly's Zepbound Receives FDA Approval for Sleep Apnea
NASDAQ · 1h ago
Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark.
Barron‘s · 2h ago
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
NASDAQ · 3h ago
Hartford Growth Opportunities Fund Q3 2024 Commentary
Seeking Alpha · 4h ago
Hartford Healthcare Fund Q3 2024 Commentary
Seeking Alpha · 4h ago
These Stocks Are Moving the Most Today: Honda, Nissan, Qualcomm, Eli Lilly, Tesla, Rumble, and More
Barron‘s · 5h ago
Does This News From the FDA Make Eli Lilly a Buy for 2025?
The Motley Fool · 5h ago
Weekly Report: what happened at LLY last week (1216-1220)?
Weekly Report · 6h ago
Tracking Philippe Laffont's Coatue Management Portfolio - Q3 2024 Update
Seeking Alpha · 9h ago
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Benzinga · 19h ago
Materials, software stocks are best poised for H1 outperformance: Goldman Sachs
Seeking Alpha · 23h ago
3 Stocks That Could Join the Trillion-Dollar Market Cap Club Next Year
The Motley Fool · 1d ago
Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
Benzinga · 1d ago
Trending stocks in bearish pre-holiday week for U.S. stock market
Seeking Alpha · 1d ago
Novo Nordisk raises expectations for Eli Lilly after CagriSema slipup
Seeking Alpha · 2d ago
If I Had To Invest $100,000 In A Dividend Growth Portfolio Right Now, Here's What I Would Buy
Seeking Alpha · 2d ago
More
Webull provides a variety of real-time LLY stock news. You can receive the latest news about Lilly Eli & Co through multiple platforms. This information may help you make smarter investment decisions.
About LLY
Eli Lilly and Company is a medicine company. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Retevmo, Tyvyt and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh and Taltz. Its neuroscience products include Cymbalta and Emgality. Its other products and therapies include Cialis and Forteo. It manufactures and distributes its products through facilities in the United States (U.S.), including Puerto Rico, and in Europe and Asia. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing, as well as clinical and pre-clinical radioligand therapies. It is also developing oral small molecule inhibitor of α4β7 integrin (known as MORF-057) for inflammatory bowel disease (IBD).